Product Information
APTENSIO XR 30 MG CAPSULE is a brand product labeled by Rhodes Pharmaceuticals L.P., priced at $8.0315 per EA under NDC 42858040445. Its NADAC has been published 267 times since Jun 20, 2018.
FDA first approved this application on Apr 17, 2015. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858040445
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
10/22/2025
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA205831FDA Approved
4/17/2015
TE Code
AB3
On Market Since
4/17/2015
Pharmacological Classes
Price Statistics
The NADAC for APTENSIO XR 30 MG CAPSULE has been published 267 times since Jun 20, 2018, and over the history we have for it it has risen 7.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.0315 per EA |
|---|---|
| All-time high | $8.0315 (Aug 19, 2026) |
| All-time low | $7.4943 (Jun 20, 2018) |
| 52-week high | $8.0315 |
| 52-week low | $8.0096 |
| Median price | $8.0080 |
| Average price | $7.8996 |
| Largest weekly change | +6.0% (Aug 7, 2019) |
| Weeks tracked | 267 |
| Tracking since | Jun 20, 2018 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of APTENSIO XR 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for APTENSIO XR 30 MG CAPSULE, manufactured by Rhodes Pharmaceuticals L.P., is $8.0315 per EA (NDC 42858040445), effective Aug 19, 2026.
How has the price of APTENSIO XR 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for APTENSIO XR 30 MG CAPSULE has risen 7.2%. It has been tracked across 267 weekly CMS publications since Jun 20, 2018.
What are the highest and lowest recorded NADAC prices for APTENSIO XR 30 MG CAPSULE?
Since Jun 20, 2018, the NADAC for APTENSIO XR 30 MG CAPSULE has ranged from a low of $7.4943 (Jun 20, 2018) to a high of $8.0315 (Aug 19, 2026), with a median of $8.0080 per EA.
Are there cheaper alternatives to APTENSIO XR 30 MG CAPSULE?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE CD 30 MG CAP, is $1.8984 per EA — about 76% below APTENSIO XR 30 MG CAPSULE.
Who manufactures APTENSIO XR 30 MG CAPSULE?
APTENSIO XR 30 MG CAPSULE (NDC 42858040445) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a brand product.